Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.
Marta Pineda-MoncusíSonia ServitjaIgnasi TusquetsAdolfo Diez-PerezAlbora RialMaria Lourdes CosIsabel CampodarveJaime Rodriguez-MoreraNatalia García-GiraltXavier NoguésPublished in: Breast cancer research and treatment (2019)
ClinicalTrials.gov: NCT03811509. Registered 28 January 2018-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03811509 .